Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1951 2
1952 4
1953 3
1955 2
1960 1
1963 1
1982 1
1984 1
1989 1
1990 24
1991 74
1992 138
1993 230
1994 234
1995 318
1996 350
1997 390
1998 408
1999 430
2000 483
2001 527
2002 626
2003 620
2004 635
2005 671
2006 640
2007 625
2008 640
2009 671
2010 697
2011 751
2012 759
2013 739
2014 720
2015 763
2016 671
2017 723
2018 734
2019 798
2020 1021
2021 1074
2022 965
2023 886
2024 414

Text availability

Article attribute

Article type

Publication date

Search Results

18,620 results

Results by year

Filters applied: . Clear all
Page 1
Drugs for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 May 18;62(1598):73-80. Med Lett Drugs Ther. 2020. PMID: 32555118 No abstract available.
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Xie M, Tang T, Liang H. Xie M, et al. Clin Cardiol. 2023 Aug;46(8):886-898. doi: 10.1002/clc.24082. Epub 2023 Jul 11. Clin Cardiol. 2023. PMID: 37432701 Free PMC article. Review.
The results of the network meta-analysis showed that a total of 11 single-pill combination antihypertensive drugs were included, namely: Amlodipine/valsartan, Telmisartan/amlodipine, Losartan/HCTZ, Candesartan/HCTZ, Amlodipine/benazepril, Telmisartan/HCTZ, Valsar
The results of the network meta-analysis showed that a total of 11 single-pill combination antihypertensive drugs were included, namely: Aml …
The effect of angiotensin II receptor blockers on hyperuricemia.
Wolff ML, Cruz JL, Vanderman AJ, Brown JN. Wolff ML, et al. Ther Adv Chronic Dis. 2015 Nov;6(6):339-46. doi: 10.1177/2040622315596119. Ther Adv Chronic Dis. 2015. PMID: 26568810 Free PMC article. Review.
The objective of this review was to explore the efficacy of angiotensin II receptor blockers (ARBs) for the treatment of hyperuricemia in individuals diagnosed with gout or hyperuricemia defined as 7 mg/dl at baseline. ...The following search terms wer …
The objective of this review was to explore the efficacy of angiotensin II receptor blockers (ARBs) for the trea …
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.
Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Oparil S, et al. J Clin Hypertens (Greenwich). 2001 Sep-Oct;3(5):283-91, 318. doi: 10.1111/j.1524-6175.2001.01136.x. J Clin Hypertens (Greenwich). 2001. PMID: 11588406 Free PMC article. Clinical Trial.
The reduction of sitting cuff DBP with olmesartan (11.5 mm Hg), the primary efficacy variable of this study, was significantly greater than with losartan, valsartan, and irbesartan (8.2, 7.9, and 9.9 mm Hg, respectively). ...The reduction in mean 24-hour SBP with ol …
The reduction of sitting cuff DBP with olmesartan (11.5 mm Hg), the primary efficacy variable of this study, was significantly greater than …
Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.
Kamal A, Fain C, Park A, Wang P, Gonzalez-Velez E, Leffler DA, Hutfless SM. Kamal A, et al. Gastroenterol Rep (Oxf). 2019 Jun;7(3):162-167. doi: 10.1093/gastro/goz019. Epub 2019 Jun 1. Gastroenterol Rep (Oxf). 2019. PMID: 31217979 Free PMC article. Review.
The ARBs listed in the case reports were olmesartan (233 users; 94.0%), telmisartan (5 users; 2.0%), irbesartan (4 users; 1.6%), valsartan (3 users; 1.2%), losartan (2 users; 0.8%) and eprosartan (1 user; 0.4%). ...
The ARBs listed in the case reports were olmesartan (233 users; 94.0%), telmisartan (5 users; 2.0%), irbesartan (4 users; 1.6%), valsarta
Angiotensin II receptor blockers induce autophagy in prostate cancer cells.
Woo Y, Jung YJ. Woo Y, et al. Oncol Lett. 2017 May;13(5):3579-3585. doi: 10.3892/ol.2017.5872. Epub 2017 Mar 17. Oncol Lett. 2017. PMID: 28529582 Free PMC article.
Angiotensin II receptor blockers (ARBs) are anti-hypertensive drugs that competitively inhibit the binding of angiotensin II to its receptor, resulting in blood vessel dilation and the reduction of blood pressure. ...In the present study, the anticance
Angiotensin II receptor blockers (ARBs) are anti-hypertensive drugs that competitively inhibit the binding of an
Angiotensin II receptor blockers: review of the binding characteristics.
Siragy H. Siragy H. Am J Cardiol. 1999 Nov 18;84(10A):3S-8S. doi: 10.1016/s0002-9149(99)00727-4. Am J Cardiol. 1999. PMID: 10588088 Review.
Several angiotensin II receptor blockers (ARBs), including candesartan cilexetil, irbesartan, losartan, telmisartan, and valsartan, are currently approved by the US Food and Drug Administration (FDA) for the treatment of patients with hyp …
Several angiotensin II receptor blockers (ARBs), including candesartan cilexetil, irbesartan, losartan, t …
Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan - Systematic Review and Network Meta-Analysis.
Nakajima T, Oh A, Saita S, Yoshida T, Ohishi M, Nishigaki N. Nakajima T, et al. Circ Rep. 2020 Sep 18;2(10):576-586. doi: 10.1253/circrep.CR-20-0076. Circ Rep. 2020. PMID: 33693183 Free PMC article.
Background: Angiotensin II receptor blockers (ARBs) are widely used for the management of hypertension in Japan; however, comparative efficacy data within the ARB drug class remain limited. Methods and Results: This systematic literature review identif …
Background: Angiotensin II receptor blockers (ARBs) are widely used for the management of hypertension in Japan; …
Angiotensin II receptor blockers in older patients.
Weber MA. Weber MA. Am J Geriatr Cardiol. 2004 Jul-Aug;13(4):197-205; quiz 206-7. doi: 10.1111/j.1076-7460.2004.03701.x. Am J Geriatr Cardiol. 2004. PMID: 15269566 Review.
Treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers has been shown to improve many of the complications of hypertension, including left ventricular hypertrophy and renal disease. Results of recent key studies su …
Treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers has been shown to i …
Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
Warner KK, Visconti JA, Tschampel MM. Warner KK, et al. Ann Pharmacother. 2000 Apr;34(4):526-8. doi: 10.1345/aph.19294. Ann Pharmacother. 2000. PMID: 10772441 Review.
OBJECTIVE: To determine the safety of using angiotensin II receptor blockers in patients who have experienced angioedema following treatment with angiotensin-converting enzyme (ACE) inhibitors. ...Recent case reports, however, document angioedema follo …
OBJECTIVE: To determine the safety of using angiotensin II receptor blockers in patients who have experienced an …
18,620 results
You have reached the last available page of results. Please see the User Guide for more information.